ID   LCN1-cis
AC   CVCL_C4AL
DR   Wikidata; Q116049676
RX   PubMed=25826333;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C5672; Lung large cell neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C4AI ! LCN1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
RX   PubMed=25826333; DOI=10.1371/journal.pone.0121460; PMCID=PMC4380450;
RA   Katono K., Sato Y., Jiang S.-X., Kobayashi M., Nagashio R., Ryuge S.,
RA   Fukuda E., Goshima N., Satoh Y., Saegusa M., Masuda N.;
RT   "Prognostic significance of MYH9 expression in resected non-small cell
RT   lung cancer.";
RL   PLoS ONE 10:e0121460.1-e0121460.14(2015).
//